Orliloss (Orlistat)

Orlistat, the active ingredient in Orliloss, is a lipase inhibitor presented as a oral tablet for oral use. It reduces the absorption of dietary fats and is used in the management of obesity in adults.

GNH USA supplies Orliloss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orlistat acts ​     ​  ​  ​  ​  ​  ​  ​  ​  ​   ​  ​   - Obesity:               ...  ...  ...  .... ...... ... …  - Over‑   .... … ... … ...

Common    ....